We are live on ! Find out more
ECM

ETrade Capital Management Portfolio holdings

AUM $5.37B
1-Year Est. Return 10.84%
This Fund
S&P 500
This Quarter Est. Return
-0.99%
1 Year Est. Return
+10.84%
3 Year Est. Return
+26.27%
5 Year Est. Return
+59.01%
10 Year Est. Return
AUM
$3.11B
AUM Growth
-$13.6M
Cap. Flow
+$27.5M
Cap. Flow %
0.88%
Top 10 Hldgs %
54.84%
Holding
799
New
68
Increased
322
Reduced
351
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 5.12%
2 Healthcare 4.68%
3 Financials 4.53%
4 Industrials 2.92%
5 Consumer Discretionary 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCI icon
101
Crown Castle
CCI
$33.3B
$3.42M 0.11%
31,213
-6,489
-17% -$704K
LMT icon
102
Lockheed Martin
LMT
$134B
$3.42M 0.11%
10,120
-274
-3% -$93.3K
VIG icon
103
Vanguard Dividend Appreciation ETF
VIG
$111B
$3.31M 0.11%
32,735
-299
-0.9% -$31K
TT icon
104
Trane Technologies
TT
$100B
$3.31M 0.11%
38,658
-1,767
-4% -$159K
D icon
105
Dominion Energy
D
$60.8B
$3.28M 0.11%
48,684
-1,321
-3% -$97.5K
ADBE icon
106
Adobe
ADBE
$99.5B
$3.26M 0.1%
15,087
+182
+1% +$37K
ORCL icon
107
Oracle
ORCL
$374B
$3.25M 0.1%
71,095
-746
-1% -$37.1K
DLTR icon
108
Dollar Tree
DLTR
$24.4B
$3.21M 0.1%
33,778
-7,722
-19% -$810K
BABA icon
109
Alibaba
BABA
$293B
$3.16M 0.1%
17,221
+1,951
+13% +$367K
DUK icon
110
Duke Energy
DUK
$97.8B
$3.15M 0.1%
40,607
-1,309
-3% -$101K
RTN
111
DELISTED
Raytheon Company
RTN
$3.09M 0.1%
14,319
-2,796
-16% -$579K
BMY icon
112
Bristol-Myers Squibb
BMY
$133B
$3.05M 0.1%
48,266
+973
+2% +$62.6K
TMO icon
113
Thermo Fisher Scientific
TMO
$213B
$3.05M 0.1%
14,773
-3,366
-19% -$707K
GIS icon
114
General Mills
GIS
$19.1B
$3.04M 0.1%
67,575
+673
+1% +$36.5K
NGG icon
115
National Grid
NGG
$80.4B
$3.02M 0.1%
60,486
+3,192
+6% +$156K
PBP icon
116
Invesco S&P 500 BuyWrite ETF
PBP
$354M
$3M 0.1%
142,540
-136,582
-49% -$2.91M
BA icon
117
Boeing
BA
$171B
$2.97M 0.1%
9,054
-1,120
-11% -$378K
CL icon
118
Colgate-Palmolive
CL
$73.1B
$2.91M 0.09%
40,592
+1,060
+3% +$76.3K
ON icon
119
ON Semiconductor
ON
$31.8B
$2.88M 0.09%
117,546
-11,418
-9% -$275K
SCHX icon
120
Schwab US Large- Cap ETF
SCHX
$71.8B
$2.87M 0.09%
273,066
-17,454
-6% -$190K
WEC icon
121
WEC Energy
WEC
$35.7B
$2.87M 0.09%
45,787
+2,303
+5% +$143K
LYG icon
122
Lloyds Banking Group
LYG
$89.5B
$2.84M 0.09%
762,548
+229,978
+43% +$891K
STZ icon
123
Constellation Brands
STZ
$22.2B
$2.83M 0.09%
12,434
-2,015
-14% -$444K
VO icon
124
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$2.81M 0.09%
72,880
-101,448
-58% -$3.99M
PFF icon
125
iShares Preferred and Income Securities ETF
PFF
$13.3B
$2.79M 0.09%
74,413
+3,668
+5% +$138K

Similar funds

ETrade Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, ETrade Capital Management held 799 positions worth $3.11B, down 0.44% from $3.12B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

ETrade Capital Management's Q1 2018 filing shows 68 new, 322 increased, 351 reduced and 58 closed positions. Its largest new stake was Universal Insurance Holdings: 49,765 shares worth $1.59M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $39.2M.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.

  • ETrade Capital Management's largest Q1 2018 buy was Universal Insurance Holdings: 49,765 shares worth $1.59M.
  • ETrade Capital Management added most to Vanguard FTSE All-World ex-US ETF in Q1 2018, an estimated $70.4M increase.
  • ETrade Capital Management's biggest Q1 2018 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $39.2M.
  • ETrade Capital Management fully exited Sucampo Pharmaceuticals, Inc. in Q1 2018, selling an estimated $1.86M.
  • ETrade Capital Management's ten largest holdings make up 55% of its $3.11B portfolio in Q1 2018.
  • ETrade Capital Management opened 68 new positions and closed 58 in Q1 2018.
  • ETrade Capital Management's portfolio value fell 0.44% quarter-over-quarter to $3.11B.

Based on ETrade Capital Management's 13F filing for Q1 2018, filed 7 May 2018.